Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06324409
Other study ID # H-350
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 15, 2024
Est. completion date March 30, 2025

Study information

Verified date March 2024
Source Norwegian Institute of Public Health
Contact Paula Berstad, PhD
Phone 47 93293235
Email pabe@kreftregisteret.no
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this randomized trial is to test the effect of a reminder telephone call in the official native language in the country where the invitee is born, in addition to the reminder letter in Norwegian on participation in the National Colorectal Cancer Screening Program in Pakistani and Somalian immigrants, compared to the reminder letter in Norwegian only. The main question it aims to answer is: •Does a reminder telephone call in the language of origin increase participation in colorectal cancer screening in Pakistani and Somalian immigrants in Norway? Participants in this trial are individuals with Pakistan or Somalia as their country of birth invited to the National Colorectal Cancer Screening Program, who have not participated by mailing a faecal sample to the screening laboratory. In the intervention group, the participants will be called in the official language in their country of origin, to inform about colorectal cancer screening, in addition to the reminder letter in Norwegian language sent to all non-participants. Participants in the comparison group will only be sent the reminder letter in Norwegian language. The researchers will compare differences in the participation rate in the National Colorectal Cancer Screening Program between the intervention and comparison groups.


Description:

The aim of the project is to study the effect of reminding non-participant Somalian and Pakistani immigrant groups by a telephone call in the official native language in the country of birth, in addition to the reminder letter in Norwegian, by running a randomized trial. The outcome is participation in the National Colorectal Cancer Screening Program by taking a faecal sample with a mailed test kit. The design of the trial is a parallel two-arm intervention study, with 1:1 randomization to intervention or control. The intervention consists of a reminder both as telephone call in the native language of the non-participant's country of birth and the standard reminder letter (sent digitally or in mail) in Norwegian from the National Colorectal Cancer Screening Program. The timepoint of the telephone call will be during a week after the reminder letter has been mailed to the non-participant. The information to be given in the reminder call will include the same information as given in the reminder letter, but it will be asked additionally whether the invitee has understood the invitation and whether he/she has any questions. A new faecal sample kit will be sent on request. The control arm will consist of screening practice as usual, which is the standard reminder letter in Norwegian from the National Colorectal Cancer Screening Program. A new faecal sample kit will be sent on request. Masking: There is no masking in the trial. Allocation: This is a randomized trial. Participants are assigned to intervention groups by chance, using Random Integer Generator in random.org, when being assigned to the list of persons to whom a reminder is sent to. Participation rate in the National Colorectal Cancer Screening Program will be compared between the intervention and control arms. That is, comparison of the proportion of individuals who send a faecal sample in mail to the screening laboratory.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 600
Est. completion date March 30, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Pakistan or Somalia registered as country of birth - Invited to the first round of faecal screening test in the National Colorectal Cancer Screening Program in Norway - Reminder letter sent after no received faecal sample in the screening laboratory within six weeks from mailing of the faecal screening sample kit from the screening organizers Exclusion Criteria: - Individuals whose mailed reminder letter is returned to sender - Individuals whose faecal screening sample is registered in the screening laboratory 1) on the same day or the day after the reminder letter is sent out (applies to those who receive a digital reminder), or 2) on the same day or up to three days after the reminder letter is sent out (applies to those who receive a mailed reminder letter)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Reminder telephone call
A reminder telephone call with information on colorectal cancer screening in the language of origin (Urdu or Somali) in addition to the reminder letter in Norwegian (usual care)

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Norwegian Institute of Public Health

Outcome

Type Measure Description Time frame Safety issue
Primary First round screening participation Participation rate in the first colorectal cancer screening round. For each randomized individual, it is measured whether or not the faecal sample is sent to the screening laboratory by the participant in the first round of screening (yes/no). within 12 weeks (84 days) from mailing of the screening reminder letter
Secondary Overall screening participation Participation rate in all five rounds of colorectal cancer screening. For each randomized individual, it is measured to which degree faecal samples are sent to the screening laboratory by the participant (yes, in all five rounds of screening/yes, in 1-4 rounds of screening/no). within six months from mailing of the last screening round invitation (of up to five rounds)
See also
  Status Clinical Trial Phase
Recruiting NCT05536089 - ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation
Active, not recruiting NCT04392479 - TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study. Phase 3
Not yet recruiting NCT05577143 - Blood Screening for Adult Colorectal Cancer
Active, not recruiting NCT05585866 - Propofol and Sevoflurane Anesthesia in Colorectal Cancer Surgery: Incidence of Acute Kidney Injury
Recruiting NCT05573022 - Impact of a Patient Decision Aid Intervention N/A
Completed NCT02931825 - Identification of High Risk People for Colorectal Cancer and Evaluation of a Specific Surveillance System N/A
Recruiting NCT03301493 - Genomic Testing and Resulting Medical Decisions
Not yet recruiting NCT05791747 - Representations, Beliefs and Attitudes Towards Hypnosis in Patients Followed for Colorectal Cancer
Recruiting NCT05830097 - A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT04258813 - Onco-primary Care Networking to Support TEAM-based Care N/A
Active, not recruiting NCT05939440 - Interventions to Decrease Financial Toxicity N/A
Completed NCT04548765 - Evaluation of Letters Promoting Colorectal Cancer Testing N/A
Recruiting NCT04189055 - Cetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases. Phase 2
Recruiting NCT04592003 - French Colorectal ESD Cohort in Experts Centers
Withdrawn NCT04345952 - Calm for Cancer Patients Receiving Chemotherapy N/A
Completed NCT04280393 - Effectiveness and Safety of the Colonoscopy Assisted by Endocuff vs. Standard in the Colorectal Cancer Screening N/A
Not yet recruiting NCT06231576 - Digital Home-Based Prehabilitation Before Surgery N/A
Recruiting NCT04874883 - Effect of the Use of Symbiotics in Patients With Colon Cancer Phase 4
Completed NCT04074460 - Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study Phase 4
Not yet recruiting NCT06191185 - IMProving Adherence to Colonoscopy Through Teams and Technology N/A